|
|
|
Insider
Information: |
Maddaluna Anthony J |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
112,757 |
|
Indirect Shares
|
54,702 |
|
|
Direct
Value |
$3,238,640 |
|
|
Indirect Value
|
$1,579,794 |
|
|
Total
Shares |
167,459 |
|
|
Total
Value |
$4,818,434 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Pfizer Inc |
PFE |
Executive Vice President |
2016-11-09 |
112,087 |
2016-11-09 |
54,702 |
Premium* |
|
Albany Molecular Research Inc |
AMRI |
Director |
2017-08-31 |
0 |
2016-02-04 |
0 |
Premium* |
|
Intec Parent Inc. |
INDP |
Director |
2021-07-23 |
670 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PFE |
Pfizer Inc |
Executive Vice PresidentOffice |
|
2013-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
57,988 |
|
- |
|
PFE |
Pfizer Inc |
Executive Vice PresidentOffice |
|
2013-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
44,269 |
|
- |
|
INDP |
Intec Parent Inc. |
Director |
|
2021-07-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
670 |
|
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2013-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
22,777 |
98,661 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2013-12-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,208 |
59,239 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
19,180 |
102,896 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,332 |
91,514 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2014-08-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,064 |
91,276 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2014-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,818 |
81,012 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2015-02-25 |
4/A |
A |
$0.00 |
$0 |
D/D |
6,902 |
80,050 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2015-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,725 |
90,658 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2015-12-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,520 |
78,608 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2016-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,949 |
105,494 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
Director |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,802 |
11,210 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2014-02-26 |
4 |
OE |
$12.70 |
$377,127 |
D/D |
29,695 |
83,716 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
Director |
|
2016-06-15 |
4 |
A |
$14.82 |
$44,994 |
D/D |
3,036 |
5,890 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
Director |
|
2016-02-04 |
4 |
A |
$15.77 |
$45,008 |
D/D |
2,854 |
2,854 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
Director |
|
2016-12-02 |
4 |
B |
$16.46 |
$24,986 |
D/D |
1,518 |
7,408 |
2.39 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2015-02-25 |
4 |
OE |
$17.69 |
$418,351 |
D/D |
23,649 |
88,933 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2014-12-31 |
4 |
OE |
$18.19 |
$486,892 |
D/D |
26,767 |
107,900 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2016-02-24 |
4 |
OE |
$18.90 |
$1,180,362 |
D/D |
62,453 |
140,772 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2016-11-02 |
4 |
OE |
$21.03 |
$684,421 |
D/D |
32,545 |
122,087 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
Director |
|
2017-08-31 |
4 |
D |
$21.75 |
$243,818 |
D/D |
(11,210) |
0 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2013-02-28 |
4 |
OE |
$22.55 |
$448,925 |
D/D |
19,908 |
75,884 |
0 |
- |
|
PFE |
Pfizer Inc |
Executive Vice President |
|
2013-11-01 |
4 |
OE |
$25.87 |
$1,125,345 |
D/D |
43,500 |
103,627 |
0 |
- |
|
46 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|